Foreign Corrupt Practices Act: Investigations Dataset

Investigation Name: Investigation into Boston Scientific Corp's Activities in Vietnam

Trend: None

Type of investigation: Internal, SEC, DOJ

Other Agencies Investigating/Assisting with SEC/DOJ Investigation: Unknown

Whistleblower: Yes

Summary

Boston Scientific Corporation is a biomedical and biotechnology engineering firm and multinational manufacturer of medical devices. Its stock is traded on the New York Stock Exchange.

In its 10-Q filed on August 4, 2022, Boston Scientific disclosed that in response to a whistleblower letter the company had received in March 2022 alleging FCPA violations in Vietnam, it had initiated an internal investigation into the matter

In its 10-Q filed on November 3, 2022, Boston Scientific disclosed that the U.S. Attorney's office for the District of Massachusetts issued a subpoena to the company seeking documents related to the matter.

In its 10-K filed on February 23, 2023, Boston Scientific diclosed that the SEC had also issued a subpoena to the company requesting documents on the matter.

In its 10-Q filed on August 1, 2024, the company noted that it had expanded its investigation to unnamed countries beyond Vietnam.

Boston Scientific said it was cooperating with government agencies while continuing its own investigation.

This investigation is ongoing.

Protected Content

Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.

| Investigations Dataset

Investigations Dataset

Information & Summary

Investigation into Boston Scientific Corp's Activities in Vietnam

Information & Summary

Protected Content